Table 4. Comparison of the adverse effects between the control (n = 16) and experimental (n = 16) groups.

	Control (n = 16)	Experimental (n = 16)	P-value
Acute rejection	3 (18.8)	0 (0.0)	0.226
Diabetes	0 (0.0)	1 (6.3)	1.000
Hyperlipidemia	3 (18.8)	1 (6.3)	0.600
Anemia	0 (0.0)	2 (12.5)	0.484
Lung infection	7 (43.8)	3 (18.8)	0.252
Liver dysfunction	1 (6.3)	1 (6.3)	1.000
Incomplete intestinal obstruction	0 (0.0)	1 (6.3)	1.000
Fever	1 (6.3)	0 (0.0)	1.000
Perirenal hematoma	1 (6.3)	0 (0.0)	1.000

Data were presented as count and percentage and tested using Chi-square test.